false
Catalog
Medication for Opioid Use Disorder (MOUD)
Medication for Opioid Use Disorder (MOUD)
Medication for Opioid Use Disorder (MOUD)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Derek Glenn discusses medication for opioid use disorder (MAUD). He emphasizes the importance of training providers and expanding access to treatment for substance use disorder. The presentation covers medication options like buprenorphine, methadone, and naltrexone approved by the FDA. These medications work neurobiologically to relieve withdrawal symptoms, cravings, and block the euphoric effect of opioids. The video highlights the significance of reducing the gap in treatment and addressing the epidemic of overdose deaths. A patient flow with buprenorphine is outlined, detailing the initiation, stabilization, and maintenance phases of treatment. The key role of healthcare providers, patient-centered care, and multimodal approaches in addressing opioid use disorder and facilitating recovery are emphasized. Regular monitoring and engagement with patients, along with access to resources and support, are vital for successful treatment outcomes.
Keywords
opioid use disorder
medication-assisted treatment
buprenorphine
methadone
naltrexone
overdose prevention
patient-centered care
10275 W. Higgins Rd., Suite 500, Rosemont, IL 60018
Phone: 847-692-7050
Help Center
Contact Us
Privacy Policy
Terms of Use
AANA® is a registered trademark of the American Association of Nurse Anesthesiology. Privacy policy. Copyright © 2024 American Association of Nurse Anesthesiology. All rights reserved.
×
Please select your language
1
English